Hair loss is the biggest issue faced by men and women from around the world these days. Good news awaits them. Dr. Ashok Sinha has now analysed a new product called WAY 316606 to put a permanent end to hair loss issue.

MUMBAI, INDIA, June 26, 2018 /24-7PressRelease/ — At present, there is a couple of medicines approved by FDA for hair loss. They are Finasteride and Minoxidil. The issue with these medicines is that they have been found to have restricted-result-producing capabilities. Even, these medicines are not able to sustain regrown hair for a longer period. These things frustrate both the patients and doctors a lot. Further, hair transplant is not a treatment that suits all. All these factors created a constant stimulus among hair treatment specialists to look for a better solution.

Dr. Ashok Sinha has now analysed and has published on his YouTube video about the research done by Dr. Nathan Hawkshaw, who has found an excellent solution for patients with hair loss issue. Dr. Nathan and his team conducted a research on WAY 316606.

Dr. Ashok Sinha is highly confident that this medicine, which is already approved by FDA for osteoporosis, will be approved for human hair loss issue as a simple topical formulation. When it comes to reality, it is truly a revolution and very great news for patients with hair loss issue.

A team of researchers was attracted by the capabilities of hypertrichosis of some medicines. They understood the mechanism. One of them is Cyclosporin A. This immunosuppressant not only induces hypertrichosis, but it also prolongs anagen phase of hair cycle. They tested the same on mice. But, two factors that helped with hair growth in mice is not present in human hair follicles.

So, Dr. Nathan Hawkshaw and his team thought of some other mechanism for hypertrichosis. Following this stem, they treated the human hair follicle with CSA therapeutic dose. It was followed by a microarray analysis and also a situ hybridisation. They also did quantitative real-time PCR, Pharmacological assays, and Immunofluorescence Microscopy. Further process ended up with Way 316606 as effective inhibitor of SFRP1 protein. Inhibition of SFRP1 cause hair growth through WNT PATHWAY more effectively and without any side effect. However, clinical trial is yet to be done on this excellent solution.

Dr. Ashok Sinha, an MBBS is a pioneer and also an architect of the Hair Transplant Education (Hairtransplanteducation.com). He is not just a analyser, but also a hair transplant expert practicing from Mumbai. He has two pending patents in the domain of hair transplant instrumentation. He has strong desire to create most trusted system and clinic to provide hair consultation, hair care and hair transplant treatment.

For more information, please visit https://hairtransplanteducation.com


For the original version of this press release, please visit 24-7PressRelease.com here